Terms: = Bone cancer AND CXCR4, D2S201E, 7852, ENSG00000121966, P61073, NPYY3R, NPY3R, HM89, NPYRL, LESTR, HSY3RR, LCR1, fusin, WHIM, NPYR, FB22, CD184 AND Prognosis
62 results:
1. Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia.
Tam CS; Opat S; D'Sa S; Jurczak W; Lee HP; Cull G; Owen RG; Marlton P; Wahlin BE; García-Sanz R; McCarthy H; Mulligan S; Tedeschi A; Castillo JJ; Czyż J; Fernández De Larrea C; Belada D; Libby E; Matous J; Motta M; Siddiqi T; Tani M; Trněný M; Minnema MC; Buske C; Leblond V; Treon SP; Trotman J; Wu B; Yu Y; Shen Z; Chan WY; Schneider J; Allewelt H; Cohen A; Dimopoulos MA
Blood Adv; 2024 Apr; 8(7):1639-1650. PubMed ID: 38315878
[TBL] [Abstract] [Full Text] [Related]
2. Genistein and coumestrol reduce MCF-7 breast cancer cell viability and inhibit markers of preferential metastasis, bone matrix attachment and tumor-induced osteoclastogenesis.
Al-Thamiree Mezban S; Fox SW
Arch Biochem Biophys; 2023 May; 740():109583. PubMed ID: 36967033
[TBL] [Abstract] [Full Text] [Related]
3. Heterogeneity of B cell lymphopoiesis in patients with premalignant and active myeloma.
Jakubikova J; Cholujova D; Beke G; Hideshima T; Klucar L; Leiba M; Jamroziak K; Richardson PG; Kastritis E; Dorfman DM; Anderson KC
JCI Insight; 2023 Feb; 8(3):. PubMed ID: 36752202
[TBL] [Abstract] [Full Text] [Related]
4. Dynamics of cxcr4 positive circulating tumor cells in prostate cancer patients during radiotherapy.
Klusa D; Lohaus F; Franken A; Baumbach M; Cojoc M; Dowling P; Linge A; Offermann A; Löck S; Hušman D; Rivandi M; Polzer B; Freytag V; Lange T; Neubauer H; Kücken M; Perner S; Hölscher T; Dubrovska A; Krause M; Kurth I; Baumann M; Peitzsch C
Int J Cancer; 2023 Jun; 152(12):2639-2654. PubMed ID: 36733230
[TBL] [Abstract] [Full Text] [Related]
5. [Waldenström disease: News and perspectives in 2022].
Bouclet F; Krzisch D; Leblond V; Tomowiak C; Laribi K; Ysebaert L; Tournilhac O; Dartigeas C; Leprêtre S; Jondreville L;
Bull Cancer; 2023 Jan; 110(1):88-100. PubMed ID: 36229266
[TBL] [Abstract] [Full Text] [Related]
6. cancer-Associated Exosomal CBFB Facilitates the Aggressive Phenotype, Evasion of Oxidative Stress, and Preferential Predisposition to bone Prometastatic Factor of Breast cancer Progression.
Hsu CH; Ma HP; Ong JR; Hsieh MS; Yadav VK; Yeh CT; Chao TY; Lee WH; Huang WC; Kuo KT; Fong IH; Lin CC; Su CM
Dis Markers; 2022; 2022():8446629. PubMed ID: 35903297
[TBL] [Abstract] [Full Text] [Related]
7. CD44 loss of function sensitizes AML cells to the BCL-2 inhibitor venetoclax by decreasing CXCL12-driven survival cues.
Yu X; Munoz-Sagredo L; Streule K; Muschong P; Bayer E; Walter RJ; Gutjahr JC; Greil R; Concha ML; Müller-Tidow C; Hartmann TN; Orian-Rousseau V
Blood; 2021 Sep; 138(12):1067-1080. PubMed ID: 34115113
[TBL] [Abstract] [Full Text] [Related]
8. Antineoplastic effect of a diphtheria toxin-based nanoparticle targeting acute myeloid leukemia cells overexpressing cxcr4.
Pallarès V; Núñez Y; Sánchez-García L; Falgàs A; Serna N; Unzueta U; Gallardo A; Alba-Castellón L; Álamo P; Sierra J; Villaverde A; Vázquez E; Casanova I; Mangues R
J Control Release; 2021 Jul; 335():117-129. PubMed ID: 34004204
[TBL] [Abstract] [Full Text] [Related]
9. bone marrow cells are differentiated into MDSCs by BCC-Ex through down-regulating the expression of cxcr4 and activating STAT3 signalling pathway.
Liu QW; Chen Y; Li JY; Xiao L; Zhang WJ; Zhao JL; Gu HC; Wu HY; Zuo GS; Deng KY; Xin HB
J Cell Mol Med; 2021 Jun; 25(12):5497-5510. PubMed ID: 33955151
[TBL] [Abstract] [Full Text] [Related]
10. bone Metastases in Neuroendocrine Tumors: Molecular Pathogenesis and Implications in Clinical Practice.
Cives M; Pellè E; Rinzivillo M; Prosperi D; Tucci M; Silvestris F; Panzuto F
Neuroendocrinology; 2021; 111(3):207-216. PubMed ID: 32403104
[TBL] [Abstract] [Full Text] [Related]
11. Expression of cxcr4 and MMP-2 is associated with poor prognosis in patients with osteosarcoma.
Gong C; Sun K; Xiong HH; Sneh T; Zhang J; Zhou X; Yan P; Wang JH
Histol Histopathol; 2020 Aug; 35(8):863-870. PubMed ID: 32314796
[TBL] [Abstract] [Full Text] [Related]
12. Clinical Significance of cancer Stem Cell Markers CD133 and cxcr4 in Osteosarcomas.
Mardani A; Gheytanchi E; Mousavie SH; Madjd Jabari Z; Shooshtarizadeh T
Asian Pac J Cancer Prev; 2020 Jan; 21(1):67-73. PubMed ID: 31983166
[TBL] [Abstract] [Full Text] [Related]
13. Effect of CXCL12 and Its Receptors on Unpredictable Renal Cell Carcinoma.
Floranović MP; Veličković LJ
Clin Genitourin Cancer; 2020 Aug; 18(4):e337-e342. PubMed ID: 31882334
[TBL] [Abstract] [Full Text] [Related]
14. New challenges in integrated diagnosis by imaging and osteo-immunology in bone lesions.
Schiano C; Soricelli A; De Nigris F; Napoli C
Expert Rev Clin Immunol; 2019 Mar; 15(3):289-301. PubMed ID: 30570412
[TBL] [Abstract] [Full Text] [Related]
15. Intrabone transplant provides full stemness of cord blood stem cells with fast hematopoietic recovery and low GVHD rate: results from a prospective study.
Bonifazi F; Dan E; Labopin M; Sessa M; Guadagnuolo V; Ferioli M; Rizzi S; De Carolis S; Sinigaglia B; Motta MR; Bontadini A; Giudice V; Martinelli G; Arpinati M; Cavo M; Bonafé M; Storci G
Bone Marrow Transplant; 2019 May; 54(5):717-725. PubMed ID: 30232415
[TBL] [Abstract] [Full Text] [Related]
16. Progenitor Cells and Clinical Outcomes in Patients With Acute Coronary Syndromes.
Samman Tahhan A; Hammadah M; Raad M; Almuwaqqat Z; Alkhoder A; Sandesara PB; Mohamed-Kelli H; Hayek SS; Kim JH; O'Neal WT; Topel ML; Grant AJ; Sabbak N; Heinl RE; Gafeer MM; Obideen M; Kaseer B; Abdelhadi N; Ko YA; Liu C; Hesaroieh I; Mahar EA; Vaccarino V; Waller EK; Quyyumi AA
Circ Res; 2018 May; 122(11):1565-1575. PubMed ID: 29514830
[TBL] [Abstract] [Full Text] [Related]
17. The prognostic value of C-X-C motif chemokine receptor 4 in patients with sporadic malignant peripheral nerve sheath tumors.
Zhang C; Chang FY; Zhou WY; Yang JL
Chin J Cancer; 2017 Oct; 36(1):80. PubMed ID: 29020982
[TBL] [Abstract] [Full Text] [Related]
18. HIF-2α Promotes Dissemination of Plasma Cells in Multiple Myeloma by Regulating CXCL12/cxcr4 and CCR1.
Vandyke K; Zeissig MN; Hewett DR; Martin SK; Mrozik KM; Cheong CM; Diamond P; To LB; Gronthos S; Peet DJ; Croucher PI; Zannettino ACW
Cancer Res; 2017 Oct; 77(20):5452-5463. PubMed ID: 28855206
[TBL] [Abstract] [Full Text] [Related]
19. T cell acute lymphoblastic leukemia (T-ALL): New insights into the cellular origins and infiltration mechanisms common and unique among hematologic malignancies.
Vadillo E; Dorantes-Acosta E; Pelayo R; Schnoor M
Blood Rev; 2018 Jan; 32(1):36-51. PubMed ID: 28830639
[TBL] [Abstract] [Full Text] [Related]
20. Targeting the CXCL12/cxcr4 axis in acute myeloid leukemia: from bench to bedside.
Cho BS; Kim HJ; Konopleva M
Korean J Intern Med; 2017 Mar; 32(2):248-257. PubMed ID: 28219003
[TBL] [Abstract] [Full Text] [Related]
[Next]
